Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TELA Bio (TELA) Research & Development (2018 - 2025)

Historic Research & Development for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to $2.3 million.

  • Bio's Research & Development rose 1353.97% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.1 million, marking a year-over-year decrease of 368.57%. This contributed to the annual value of $8.8 million for FY2024, which is 837.92% down from last year.
  • Per Bio's latest filing, its Research & Development stood at $2.3 million for Q3 2025, which was up 1353.97% from $2.2 million recorded in Q2 2025.
  • Over the past 5 years, Bio's Research & Development peaked at $2.7 million during Q4 2022, and registered a low of $1.4 million during Q3 2021.
  • Its 5-year average for Research & Development is $2.2 million, with a median of $2.1 million in 2022.
  • As far as peak fluctuations go, Bio's Research & Development surged by 9713.99% in 2021, and later crashed by 2443.2% in 2024.
  • Bio's Research & Development (Quarter) stood at $1.7 million in 2021, then surged by 58.03% to $2.7 million in 2022, then fell by 1.5% to $2.7 million in 2023, then dropped by 24.43% to $2.0 million in 2024, then increased by 15.72% to $2.3 million in 2025.
  • Its Research & Development stands at $2.3 million for Q3 2025, versus $2.2 million for Q2 2025 and $2.5 million for Q1 2025.